09:48 AM EST - Valeant Pharmaceuticals International, Inc. : and PharmaSwiss S.A. announced today that they have signed a binding agreement for Valeant to acquire PharmaSwiss, a privately-owned branded generics and over-the-counter pharmaceutical company based in Zug, Switzerland for 350 million euros. Upon closing, PharmaSwiss is expected to have approximately 38 million euro cash on hand and no debt. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading up $2.10 at $38.59.
